GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 343 filers reported holding GLOBUS MED INC in Q3 2020. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $103,765,764 | +90.6% | 2,089,873 | +128.5% | 0.03% | +100.0% |
| Q2 2023 | $54,443,929 | +4.8% | 914,429 | -0.3% | 0.02% | 0.0% |
| Q1 2023 | $51,929,886 | +84415.8% | 916,882 | +10.8% | 0.02% | -5.6% |
| Q4 2022 | $61,444 | -99.9% | 827,298 | -4.6% | 0.02% | -10.0% |
| Q3 2022 | $51,640,000 | +19.9% | 866,860 | +13.0% | 0.02% | +33.3% |
| Q2 2022 | $43,055,000 | -22.7% | 766,887 | +1.6% | 0.02% | -11.8% |
| Q1 2022 | $55,704,000 | +27.6% | 754,957 | +24.8% | 0.02% | +30.8% |
| Q4 2021 | $43,668,000 | -3.3% | 604,813 | +2.6% | 0.01% | -13.3% |
| Q3 2021 | $45,177,000 | -4.2% | 589,533 | -3.0% | 0.02% | 0.0% |
| Q2 2021 | $47,137,000 | +15.8% | 608,024 | -7.9% | 0.02% | +15.4% |
| Q1 2021 | $40,707,000 | -14.2% | 660,104 | -9.2% | 0.01% | -23.5% |
| Q4 2020 | $47,436,000 | +24.5% | 727,329 | -5.5% | 0.02% | +6.2% |
| Q3 2020 | $38,102,000 | +2.7% | 769,495 | -1.0% | 0.02% | 0.0% |
| Q2 2020 | $37,092,000 | +1.0% | 777,476 | -10.0% | 0.02% | -15.8% |
| Q1 2020 | $36,724,000 | -33.7% | 863,484 | -8.2% | 0.02% | -5.0% |
| Q4 2019 | $55,368,000 | +6.1% | 940,361 | -7.9% | 0.02% | 0.0% |
| Q3 2019 | $52,207,000 | +29.0% | 1,021,314 | +6.7% | 0.02% | +25.0% |
| Q2 2019 | $40,480,000 | -12.4% | 956,934 | +2.3% | 0.02% | -11.1% |
| Q1 2019 | $46,211,000 | +10.6% | 935,291 | -3.1% | 0.02% | -5.3% |
| Q4 2018 | $41,793,000 | -38.6% | 965,657 | -19.5% | 0.02% | -26.9% |
| Q3 2018 | $68,052,000 | -2.7% | 1,198,970 | -13.5% | 0.03% | -7.1% |
| Q2 2018 | $69,924,000 | -19.1% | 1,385,757 | -20.1% | 0.03% | -22.2% |
| Q1 2018 | $86,385,000 | +20.2% | 1,733,938 | -0.9% | 0.04% | +20.0% |
| Q4 2017 | $71,878,000 | +31.2% | 1,748,821 | -5.1% | 0.03% | +25.0% |
| Q3 2017 | $54,784,000 | -8.8% | 1,843,340 | +1.8% | 0.02% | -14.3% |
| Q2 2017 | $60,046,000 | +10.7% | 1,811,306 | -1.1% | 0.03% | +7.7% |
| Q1 2017 | $54,244,000 | +22.4% | 1,831,360 | +2.5% | 0.03% | +18.2% |
| Q4 2016 | $44,334,000 | +21.4% | 1,786,939 | +10.4% | 0.02% | +10.0% |
| Q3 2016 | $36,520,000 | -4.4% | 1,618,090 | +0.9% | 0.02% | -9.1% |
| Q2 2016 | $38,205,000 | +1.7% | 1,603,236 | +1.3% | 0.02% | 0.0% |
| Q1 2016 | $37,572,000 | -6.7% | 1,581,986 | +9.3% | 0.02% | -12.0% |
| Q4 2015 | $40,275,000 | +39.5% | 1,447,668 | +3.6% | 0.02% | +31.6% |
| Q3 2015 | $28,877,000 | -11.5% | 1,397,664 | +10.0% | 0.02% | -5.0% |
| Q2 2015 | $32,616,000 | +9.6% | 1,270,571 | +7.8% | 0.02% | +5.3% |
| Q1 2015 | $29,759,000 | +24.7% | 1,179,072 | +17.4% | 0.02% | +18.8% |
| Q4 2014 | $23,874,000 | +29.5% | 1,004,355 | +7.1% | 0.02% | +23.1% |
| Q3 2014 | $18,441,000 | -10.5% | 937,537 | +8.8% | 0.01% | -7.1% |
| Q2 2014 | $20,608,000 | +67.5% | 861,519 | +86.2% | 0.01% | +55.6% |
| Q1 2014 | $12,303,000 | +2664.7% | 462,703 | +2000.0% | 0.01% | – |
| Q4 2013 | $445,000 | – | 22,033 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 373,254 | $26,949,000 | 17.58% |
| Next Capital Management LLC | 111,098 | $8,021,000 | 5.42% |
| Sterling Investment Advisors, Ltd. | 188,123 | $13,582,000 | 3.82% |
| Integral Health Asset Management, LLC | 180,000 | $12,996,000 | 3.60% |
| Pembroke Management, LTD | 602,447 | $43,497,000 | 3.19% |
| Godshalk Welsh Capital Management, Inc. | 73,435 | $5,302,000 | 3.02% |
| XXEC, Inc. | 51,925 | $3,420,000 | 2.92% |
| Sivik Global Healthcare LLC | 75,000 | $5,415,000 | 2.32% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 654,100 | $47,226,000 | 2.11% |
| Van Berkom & Associates Inc. | 929,856 | $67,136,000 | 1.98% |